$23.48
0.914.03%
At Close: -
$23.48
00.00%
After Hours: 1:08 PM EDT
15 minutes delayed
Beam Therapeutics
BEAMNASDAQ
Beam Therapeutics (BEAM) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBeam Therapeutics (NASDAQ:BEAM) Stock Quotes, Forecast and News Summary
Beam Therapeutics Stock (NASDAQ: BEAM) stock price, news, charts, stock research, profile.
| Open | $23.03 |
| Close | $23.48 |
| Volume / Avg. | 718.55K / 1.42M |
| Day Range | 22.72 - 23.90 |
| 52 Wk Range | 16.95 - 49.50 |
| Market Cap | $1.93B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 47 |
| Short Interest | 20.61% |
| Days to Cover | 9.52 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Beam Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Beam Therapeutics (BEAM) stock?
You can purchase shares of Beam Therapeutics (NASDAQ:BEAM) through any online brokerage.
Who are Beam Therapeutics (BEAM) competitors?
Other companies in Beam Therapeutics’s space includes: Syndax Pharmaceuticals (NASDAQ:SNDX), Protagonist Therapeutics (NASDAQ:PTGX), Apogee Therapeutics (NASDAQ:APGE), Novavax (NASDAQ:NVAX) and CG Oncology (NASDAQ:CGON).
What is the target price for Beam Therapeutics (BEAM) stock?
There is no analysis for Beam Therapeutics.
What is the forecast for Beam Therapeutics (BEAM) stock?
Beam Therapeutics has a consensus price target of $58.93.
Current stock price for Beam Therapeutics (BEAM)?
The stock price for Beam Therapeutics (NASDAQ: BEAM) is $23.48 last updated Today at July 3, 2024 at 1:08 PM EDT.
Does Beam Therapeutics (BEAM) pay a dividend?
A quarterly cash dividend of 0.23 per share of Class A Common Stock. The quarterly cash dividend was payable on March 3, 2014 to stockholders of record on February 4, 2014.
When is Beam Therapeutics (NASDAQ:BEAM) reporting earnings?
Beam Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Beam Therapeutics (BEAM) going to split?
There is no upcoming split for Beam Therapeutics.
What sector and industry does Beam Therapeutics (BEAM) operate in?
Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.